PATENT CLAIM ANALYSIS

Application Number: 15987277
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "210180"]

Abstract:
Compounds of formula (I) defined herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

Claim (Index 3):
A compound or pharmaceutically acceptable salt according to  claim 1 , wherein\n A is group of formula (Ia): B is a group of formula (IIa) or (IIe): R 1  is H or (R 8 )(R 9 )NC(O)\u2014; R 3  is linear or branched (C 1 -C 4 )alkyl-; R 5  is linear or branched (C 1 -C 4 )alkyl-, R 12 O\u2014(C 1 -C 4 )alkylene-, or R 12 O\u2014; R 8  is H; R 9  is (R 10 )(R 11 )N\u2014(C 1 -C 4 )alkylene-, wherein said (C 1 -C 4 )alkylene- in (R 10 )(R 11 )N\u2014(C 1 -C 4 )alkylene- may be optionally substituted with one or more linear or branched (C 1 -C 4 )alkyl- groups; R 10  is linear or branched (C 1 -C 4 )alkyl-; R 11  is linear or branched (C 1 -C 4 )alkyl- or and R 12 O\u2014(C 1 -C 4 )alkylene-; or R 10  and R 11  may form, together with the nitrogen atom to which they are attached, an optionally substituted 4-7 membered saturated heterocyclic monocyclic ring system, optionally containing a further oxygen or nitrogen heteroatom.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15388350', '14296730', '14895718', '14868516', '14296794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8317123190765568
- 35 USC 102 Novelty (BERT): 0.5920661909582795
- Combined Prediction Score: 0.8077477062647291
- Mean Citation Score: 514.875808
- Max Citation Score: 525.1804
- Similarity Product: 417.6411039711475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test